Refining Prediction of Atrial Fibrillation Risk in the General Population With Analysis of P-Wave Axis (from the Atherosclerosis Risk in Communities Study)
Overview
Authors
Affiliations
Adverse atrial remodeling is associated with increased risk of atrial fibrillation (AF) and can be detected by a shift in P-wave axis. We aimed to determine whether an analysis of P-wave axis can be used to improve risk prediction of AF. We included 15,102 Atherosclerosis Risk in Communities Study participants who were free of AF at baseline. Abnormal P-wave axis (aPWA) was defined as any value outside 0 to 75 degrees on study visit 12-lead electrocardiograms. AF was determined using study visit electrocardiograms, death certificates, and hospital discharge records. Multivariable Cox regression was used to estimate hazard ratios and 95% confidence intervals (CIs) for the association of aPWA with AF. The Cohorts for Heart and Aging Research in Genomic Epidemiology-AF (CHARGE-AF) risk prediction model variables served as our benchmark. Improvement in 10-year AF prediction was assessed by C-statistic, category-based net reclassification improvement, and relative integrated discrimination improvement. During a mean follow-up of 20.2 years, there were 2,618 incident AF cases. aPWA was independently associated with a 2.34-fold (95% CI 2.12 to 2.58) increased risk of AF after adjusting for CHARGE-AF risk score variables. The use of aPWA improved the C-statistic from 0.719 (95% CI 0.702 to 0.736) to 0.722 (95% CI 0.705 to 0.739), which corresponded with a net reclassification improvement of 0.021 (95% CI 0.001, 0.040) and relative integrated discrimination improvement of 0.043 (95% CI 0.018, 0.069). In conclusion, aPWA is independently associated with AF in the general population. The use of this maker modestly improves AF prediction.
Karanikola A, Tzortzi M, Kordalis A, Doundoulakis I, Antoniou C, Laina A J Clin Med. 2025; 14(3).
PMID: 39941478 PMC: 11818469. DOI: 10.3390/jcm14030809.
Association of abnormal P-wave parameters with all-cause mortality in diffuse large B-cell lymphoma.
Du H, Tang Q, Ning Y, Wang H, Nie Z, Wang M Sci Rep. 2024; 14(1):29606.
PMID: 39609581 PMC: 11604949. DOI: 10.1038/s41598-024-81039-0.
Hung Y, Lin C, Lin C, Lee C, Fang W, Lee C J Med Syst. 2024; 48(1):67.
PMID: 39028354 DOI: 10.1007/s10916-024-02088-6.
Role of Cardiac Biomarkers in Stroke and Cognitive Impairment.
Johansen M, von Rennenberg R, Nolte C, Jensen M, Bustamante A, Katan M Stroke. 2024; 55(9):2376-2384.
PMID: 39016019 PMC: 11347090. DOI: 10.1161/STROKEAHA.123.044143.
Park S, Kim Y, Lee M, Lee S, Bae J, Lee J Front Neurol. 2024; 14:1287609.
PMID: 38249733 PMC: 10797101. DOI: 10.3389/fneur.2023.1287609.